Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Local Avastin injection for glomus tumors
MOH_2020-05-20_008921Phase 2Not yet recruiting
- Sponsor
- ד"ר שני סבוראי בנד
- Start
- May 2020
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of bevacizumab in Glomus tumors (PGL), sponsored by ד"ר שני סבוראי בנד. Planned start May 2020; status: not yet recruiting.
02
Drugs
bevacizumab
03
Conditions
Glomus tumors (PGL)
Beyond the preview
Go deeper on MOH_2020-05-20_008921.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on MOH_2020-05-20_008921.